In a new study, researchers at McMaster University have identified a potential treatment for Sandhoff and Tay-Sachs ...

The financial struggles of genetic testing and ancestry company 23andMe are raising questions about the security of customers ...

Genetic technology in medicine has evolved to the point where it is now being used to improve care and outcomes for ...

The company announced Monday that it would lay off around 40% of its workforce -- about 200 employees -- and close its drug ...

Researchers have identified an FDA-approved drug that could offer new hope for patients with the rare, fatal genetic ...

Me just dropped some major news in a tough year for the genetic testing company. After months of financial challenges, data ...

Lisa Bancroft is among thousands of people who have been tested for the faulty BRCA gene since its discovery 30 years ago.

Researchers at the University of Copenhagen have developed a new weight-loss drug that may surpass the effectiveness of ...

To determine the type and severity of a cancer, pathologists typically analyze thin slices of a tumor biopsy under a microscope.

To determine the type and severity of a cancer, pathologists typically analyze thin slices of a tumor biopsy under a ...

Meanwhile, Hims & Hers tackles the GLP-1 shortage with a new app; Eli Lilly releases data on tirzepatide efficacy; 23andMe faces privacy concerns; and more.

Medically reviewed by Mary Choy, PharmD Amlodipine is a commonly prescribed calcium channel blocker medication used to treat ...